These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 25512239)

  • 1. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for Colorectal Liver Metastases (CRLM).
    Wagner D; Karitnig R; Wienerroither V; Hau HM; Lederer A; Sucher R; Kornprat P
    Anticancer Res; 2024 May; 44(5):2177-2183. PubMed ID: 38677767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection.
    Lodewick TM; Roeth AA; Olde Damink SW; Alizai PH; van Dam RM; Gassler N; Schneider M; Dello SA; Schmeding M; Dejong CH; Neumann UP
    J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):155-63. PubMed ID: 26136191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases.
    Runkel M; Diallo TD; Lang SA; Bamberg F; Benndorf M; Fichtner-Feigl S
    World J Surg; 2021 Jul; 45(7):2218-2226. PubMed ID: 33842995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
    Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
    Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
    Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
    Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
    Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of association between CT-assessed skeletal muscle mass and long-term oncological outcomes after curative therapy for colorectal liver metastasis.
    Meyer YM; Galjart B; Waalboer RB; Olthof PB; van Vugt JLA; Grünhagen DJ; Verhoef C
    HPB (Oxford); 2022 Oct; 24(10):1711-1719. PubMed ID: 35550727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.
    Tegels JJ; van Vugt JL; Reisinger KW; Hulsewé KW; Hoofwijk AG; Derikx JP; Stoot JH
    J Surg Oncol; 2015 Sep; 112(4):403-7. PubMed ID: 26331988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma.
    Fehrenbach U; Wuensch T; Gabriel P; Segger L; Yamaguchi T; Auer TA; Beetz NL; Denecke C; Kröll D; Raakow J; Knitter S; Chopra S; Thuss-Patience P; Pratschke J; Hamm B; Biebl M; Geisel D
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition and outcome in patients undergoing resection of colorectal liver metastases.
    van Vledder MG; Levolger S; Ayez N; Verhoef C; Tran TC; Ijzermans JN
    Br J Surg; 2012 Apr; 99(4):550-7. PubMed ID: 22246799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of body composition profile on outcomes following colorectal cancer surgery.
    Malietzis G; Currie AC; Athanasiou T; Johns N; Anyamene N; Glynne-Jones R; Kennedy RH; Fearon KC; Jenkins JT
    Br J Surg; 2016 Apr; 103(5):572-80. PubMed ID: 26994716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
    Lee J; Hong YP; Shin HJ; Lee W
    J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
    Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
    Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma - analysis from SWOG S1505.
    Sohal DPS; Boutin RD; Lenchik L; Kim J; Beg MS; Wang-Gillam A; Wade JL; Guthrie KA; Chiorean EG; Ahmad SA; Lowy AM; Philip PA; Chang VT
    J Gastrointest Surg; 2024 Mar; 28(3):232-235. PubMed ID: 38445914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.